(5.ALPHA.,17.ALPHA.)-N-(2,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE
UNII 6S8DGN8P3M
Substance Identification & Data
This profile provides standardized clinical and technical data for (5.alpha.,17.alpha.)-n-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6S8DGN8P3M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2102935-76-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H30F6N2O2 JWJOTENAMICLJG-UWKVNAJESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (5.alpha.,17.alpha.)-n-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.